Right Ventricular Dysfunction in Hypertrophic Cardiomyopathy

  • Lucian Florin Dorobanţu


Hypertrophic cardiomyopathy (HCM) is one of the primary diseases affecting the cardiac muscle and is characterized by heterogeneous genetic, morphological, functional and clinical features. It is the most common genetic heart disease, with an estimated prevalence at 0.2%. Structural abnormalities in the RV are present in a great proportion of patient with HCM. With advancements of echocardiography, and improved diagnosis the percentage of RV hypertrophy (RVH) in HCM is augmented to 53%. The main common finding in this situation is the mild ventricular obstruction.

There are no specific symptoms related to the RV dysfunction in HCM. There is no demonstrated correlation between the sites and the severity of the LV obstruction and the clinical symptoms. Therefore, the development of the heart failure signs and symptoms, ventricular and/or supraventricular arrhythmias or sudden deaths are most often impossible to predict. There is no specific medical treatment for RV dysfunction in HCM. In absence of the significant gradient in the LV outflow, the patients are treated with “normal” therapy of HCM, consisting in beta-blockers and calcium-channel blockers. In case of significant RV gradient, surgical intervention has been reported. The standard surgical approach consist in myectomy (Morrow procedure) and relief of the RV gradient by resection and patch enlargement. The results are very good, symptoms are improved at intermediate-term follow-up and sudden deaths are rare.


Right ventricle Hypertrophic cardiomyopathy Right ventricle dysfunction 


  1. 1.
    Wynne J, Braunwald E. The cardiomyopathies and myocarditides. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. 5th ed. Philadelphia: WB Saunders Company; 1997. p. 1414.Google Scholar
  2. 2.
    Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29:270–6.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy (first of two parts). N Engl J Med. 1987;316:780–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy (second of two parts). N Engl J Med. 1987;316:844852.CrossRefGoogle Scholar
  5. 5.
    Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958;20:1–8.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    McKenna WJ, Kleinebenne A, Nihoyannopoulos P, Foale R. Echocardiographic measurement of right ventricular wall thickness in hypertrophic cardiomyopathy: relation to clinical and prognostic features. J Am Coll Cardiol. 1988;11:351–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Seo T, Yokota Y, Kumaki T, Takarada A, Kubo M, Kaku K, Toh S, Fukuzaki H. Regional right ventricular hypertrophy in hypertrophic cardiomyopathy and hypertension. J Cardiogr. 1985;15:339–46.PubMedGoogle Scholar
  9. 9.
    Rosca M, Calin A, Beladan C, et al. Right ventricular remodeling, its correlates and its clinical impact in hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2015;28(11):1329–38.CrossRefPubMedGoogle Scholar
  10. 10.
    Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995;26:1699–708.CrossRefPubMedGoogle Scholar
  11. 11.
    Maron BJ, McIntosh CL, Klues HG, Cannon RO, Roberts WC. Morphologic basis for obstruction of right ventricular outflow in hypertrophic cardiomyopathy. Am J Cardiol. 1993;71:1089–94.CrossRefPubMedGoogle Scholar
  12. 12.
    Maron MS, Hauser TH, Dubrow E, Horst TA, Kissinger KV, Udelson JE, Manning WJ. Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol. 2007;100(8):1293.CrossRefPubMedGoogle Scholar
  13. 13.
    D’Andrea A, Caso P, Bossone E, Scarafile R, Riegler L, Di Salvo G, et al. Right ventricular myocardial involvement in either physiological or pathological left ventricular hypertrophy: an ultrasound speckle-tracking two-dimensional strain analysis. Eur J Echocardiogr. 2010;11:492–500.CrossRefPubMedGoogle Scholar
  14. 14.
    Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol. 2006;47:789–93.CrossRefPubMedGoogle Scholar
  15. 15.
    Rosca M, Popescu BA, Beladan CC, Călin A, Muraru D, Popa EC, et al. Left atrial dysfunction as a correlate of heart failure symptoms in hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2010;23:1090–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775–85.CrossRefPubMedGoogle Scholar
  17. 17.
    Maron BJ. Hypertrophic cardiomyopathy. A systematic review. JAMA. 2002;287:1308–20.PubMedGoogle Scholar
  18. 18.
    Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004;363:1881–91.CrossRefPubMedGoogle Scholar
  19. 19.
    Spirito P, Autore C. Management of hypertrophic cardiomyopathy. BMJ. 2006;332(7552):1251–5.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Quintana E, Johnson N, Rotes S, et al. Surgery for biventricular obstruction in hypertrophic cardiomyopathy in children and youn adults: technique and outcomes. Eur J Cardiothorac Surg. 2015;47:1006–12.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Lucian Florin Dorobanţu
    • 1
  1. 1.Cardiomyopathy Center, Monza HospitalBucharestRomania

Personalised recommendations